Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
6 Pt 1
pubmed:dateCreated
2007-11-26
pubmed:abstractText
Outcomes in patients with type 2 diabetes mellitus (DM) can differ based on the antidiabetic medication that is used. Thiazolidinediones (TZDs) are a newer class of agents used for the treatment of type 2 DM. No previous study has compared health care utilization associated with the 2 TZDs on the market.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jun
pubmed:issn
1879-114X
pubmed:author
pubmed:copyrightInfo
(c) 2007 Excerpta Medica, Inc.
pubmed:issnType
Electronic
pubmed:volume
29
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1306-15
pubmed:dateRevised
2009-9-18
pubmed:meshHeading
pubmed-meshheading:18036392-Adolescent, pubmed-meshheading:18036392-Adult, pubmed-meshheading:18036392-Databases, Factual, pubmed-meshheading:18036392-Diabetes Mellitus, Type 2, pubmed-meshheading:18036392-Emergency Service, Hospital, pubmed-meshheading:18036392-Female, pubmed-meshheading:18036392-Health Care Costs, pubmed-meshheading:18036392-Hospitalization, pubmed-meshheading:18036392-Humans, pubmed-meshheading:18036392-Hypoglycemic Agents, pubmed-meshheading:18036392-Male, pubmed-meshheading:18036392-Medicaid, pubmed-meshheading:18036392-Medication Adherence, pubmed-meshheading:18036392-Middle Aged, pubmed-meshheading:18036392-Multivariate Analysis, pubmed-meshheading:18036392-Retrospective Studies, pubmed-meshheading:18036392-Thiazolidinediones, pubmed-meshheading:18036392-United States
pubmed:year
2007
pubmed:articleTitle
Comparisons of rosiglitazone versus pioglitazone monotherapy introduction and associated health care utilization in Medicaid-enrolled patients with type 2 diabetes mellitus.
pubmed:affiliation
Department of Pharmacy Practice and Administration, The Ohio State University, Columbus, Ohio 43210, USA. balkrishnan.l@osu.edu
pubmed:publicationType
Journal Article, Comparative Study, Research Support, Non-U.S. Gov't